Farmacogenómica del Cáncer ; Pharmacogenomic of cancer
Gedelcan
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (44)
2024
-
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
British Journal of Surgery, Vol. 111, Núm. 1
-
Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago
World Journal of Emergency Surgery, Vol. 19, Núm. 1
2023
-
Risk factors for anastomotic leakage and postoperative outcomes after total and subtotal colectomy: A nationwide retrospective cohort study (RIALTCOT Study Collaborative Group)
Colorectal Disease, Vol. 25, Núm. 3, pp. 420-430
-
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients
British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876
2022
-
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity
Biomedicines, Vol. 10, Núm. 3
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study
Journal of Clinical Anesthesia, Vol. 74
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749
2020
-
Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial
Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25
-
Schwann cell hamartoma as an incidental finding in a colonoscopy
Gastroenterologia y Hepatologia, Vol. 43, Núm. 9, pp. 516-517
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12
2018
-
Aeem-sego position statement on menopausal hormone therapy
Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234
2016
2007
-
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease
Inflammatory Bowel Diseases, Vol. 13, Núm. 5, pp. 585-590
2004
-
Reviewing the mechanism of action of thiopurine drugs: Towards a new paradigm in clinical practice
Medical Science Monitor, Vol. 10, Núm. 11
2003
-
Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer
International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790
1999
-
Bullous and hemorrhagic lesions
Archives of Dermatology, Vol. 135, Núm. 1, pp. 81
1998
-
Superficial granulomatous pyoderma
Dermatology, Vol. 196, Núm. 3, pp. 358-360